Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06313983
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-03-05
Brief Title:
A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
Sponsor:
Tianjin Hemay Pharmaceutical Co Ltd
Organization:
Ganzhou Hemay Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-05
First Submit QC Date:
March 10 2024
Study First Post Date:
2024-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-10
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL